Eurofins Scientific Acquires Majority Stake in Ajal for Laboratories (Riyadh)
June 2, 2022
Eurofins Scientific has agreed to acquire a majority stake in Ajal for Laboratories, a Riyadh-based food, tobacco and pharmaceutical testing laboratory that generated around €15m revenue in 2021. The transaction is Eurofins' first acquisition in the Kingdom of Saudi Arabia and is intended to expand its local testing network and support growing food production and biopharma sectors in the Middle East.
- Buyers
- Eurofins Scientific
- Targets
- Ajal for Laboratories
- Sellers
- Shareholders of Saudi Ajal
- Industry
- Healthcare Services
- Location
- Riyadh Province, Saudi Arabia
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Eurofins Scientific S.E. Acquires Labormar in Colombia
July 8, 2024
Healthcare Services
Eurofins Scientific S.E. has completed the acquisition of Labormar, a Barranquilla-based laboratory, expanding Eurofins' testing capabilities and presence in Colombia and Latin America. Labormar, now operating as Eurofins Labormar, brings ~90 employees across a laboratory and nine logistics/sampling hubs serving food, feed, cosmetic, pharmacological and environmental testing markets.
-
Eurofins Scientific Acquires Infinity Laboratories
September 16, 2024
Healthcare Services
Eurofins Scientific has completed the acquisition of Infinity Laboratories, a U.S.-based contract testing group that operates eight laboratories and employs approximately 100 staff. The deal expands Eurofins' microbiology and package testing footprint across the United States, enhancing its BioPharma and Medical Device testing capabilities and geographic coverage.
-
Eurofins Scientific Acquires WESSLING Hungary
July 29, 2022
Environmental Services
Eurofins Scientific has completed the acquisition of WESSLING Hungary, a Budapest-based environmental, food and BioPharma product testing laboratory. The deal expands Eurofins’ laboratory footprint and capabilities in Hungary and Central and Eastern Europe, adding ~€15m in revenue and over 300 employees.
-
Eurofins Discovery Acquires DiscoveryBioMed
July 5, 2022
Biotechnology
Eurofins Discovery has acquired DiscoveryBioMed, a Birmingham, Alabama–based contract research organization specializing in human primary- and immortalized-cell based bioassays. The acquisition strengthens Eurofins Discovery’s translational biology and human cell assay capabilities to expand its drug discovery services portfolio.
-
Stirling Square Acquires Eurofins Digital Testing
September 1, 2022
IT Services
Stirling Square Capital Partners has agreed to acquire Eurofins Scientific’s Digital Testing business for €220 million on a cash- and debt-free basis. The divested business — which was established in 2015, provides digital testing, quality assurance and cybersecurity services and employs over 600 staff — will be subject to regulatory approvals and customary closing conditions; Baird acted as exclusive financial advisor to Eurofins.
-
Eurofins Scientific Acquires bioskin GmbH
August 4, 2021
Healthcare Services
Eurofins Scientific has completed the acquisition of bioskin GmbH, a Hamburg-based dermatology-focused CRO that provides clinical trials for drugs, medical devices, food supplements and advanced cosmetics. The deal expands Eurofins' clinical study management and dermatology capabilities in Germany and strengthens its Cosmetics & Personal Care testing offering.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.